Mutator/Hypermutable fetal/juvenile metakaryotic stem cells and human colorectal carcinogenesis.

MLA

Kini, Lohith G., et al. “Mutator/Hypermutable Fetal/Juvenile Metakaryotic Stem Cells and Human Colorectal Carcinogenesis.” Frontiers in Oncology, vol. 3, Oct. 2013, p. 267. EBSCOhost, https://doi.org/10.3389/fonc.2013.00267.

APA

Kini, L. G., Herrero-Jimenez, P., Kamath, T., Sanghvi, J., Gutierrez, E., Jr, Hensle, D., Kogel, J., Kusko, R., Rexer, K., Kurzweil, R., Refinetti, P., Morgenthaler, S., Koledova, V. V., Gostjeva, E. V., & Thilly, W. G. (2013). Mutator/Hypermutable fetal/juvenile metakaryotic stem cells and human colorectal carcinogenesis. Frontiers in Oncology, 3, 267. https://doi.org/10.3389/fonc.2013.00267

Chicago

Kini, Lohith G, Pablo Herrero-Jimenez, Tushar Kamath, Jayodita Sanghvi, Efren Gutierrez Jr, David Hensle, John Kogel, et al. 2013. “Mutator/Hypermutable Fetal/Juvenile Metakaryotic Stem Cells and Human Colorectal Carcinogenesis.” Frontiers in Oncology 3 (October): 267. doi:10.3389/fonc.2013.00267.